[613] | 1 | DVBCWLQ1 ;ALB/JAM LIVER, GALL BLADDER AND PANCREAS WKS TEXT - 1 ; 19 FEBRUARY 1999
|
---|
| 2 | ;;2.7;AMIE;**36**;Apr 10, 1995
|
---|
| 3 | ;
|
---|
| 4 | ;
|
---|
| 5 | TXT ;
|
---|
| 6 | ;;
|
---|
| 7 | ;;A. Review of Medical Records: This may be of particular importance when
|
---|
| 8 | ;;hepatitis C (HCV) or chronic liver disease is claimed as related to service.
|
---|
| 9 | ;;
|
---|
| 10 | ;;
|
---|
| 11 | ;;B. Medical History (Subjective Complaints):
|
---|
| 12 | ;;
|
---|
| 13 | ;;Comment on:
|
---|
| 14 | ;; 1. Vomiting, hematemesis, or melena.
|
---|
| 15 | ;; 2. Current treatment-type (medication, diet, enzymes, etc.), duration,
|
---|
| 16 | ;; response, side effects.
|
---|
| 17 | ;; 3. Episodes of colic or other abdominal pain, fever, distention, nausea, or
|
---|
| 18 | ;; vomiting. Describe the duration, frequency, severity, treatment, and
|
---|
| 19 | ;; response to treatment.
|
---|
| 20 | ;; 4. Fatigue, weakness, depression, or anxiety, and their severity.
|
---|
| 21 | ;; 5. Past biliary tract surgery.
|
---|
| 22 | ;; 6. When chronic liver disease is claimed:
|
---|
| 23 | ;; * Record history of and dates for any risk factors for liver disease,
|
---|
| 24 | ;; including transfusion or organ transplant before 1992, hemodialysis,
|
---|
| 25 | ;; tattoo, body piercing, intravenous (or intranasal cocaine) drug use,
|
---|
| 26 | ;; occupational blood exposure or other percutaneous blood exposure,
|
---|
| 27 | ;; high-risk sexual activity, etc. Intramuscular gamma globulin shots
|
---|
| 28 | ;; may be claimed as a risk factor for hepatitis C, but, to date, no
|
---|
| 29 | ;; transmission of HCV by this means has been shown.
|
---|
| 30 | ;; * Describe current symptoms of liver disease and onset of symptoms.
|
---|
| 31 | ;; * Provide history of any hepatitis in service and discuss its
|
---|
| 32 | ;; relationship to current liver disease.
|
---|
| 33 | ;; * Provide history of alcohol use/abuse, both current and past.
|
---|
| 34 | ;;
|
---|
| 35 | ;;
|
---|
| 36 | ;;C. Physical Examination (Objective Findings):
|
---|
| 37 | ;;
|
---|
| 38 | ;;Address each of the following as appropriate, and fully describe
|
---|
| 39 | ;;current findings:
|
---|
| 40 | ;; 1. Ascites.
|
---|
| 41 | ;; 2. Weight gain or loss, steatorrhea, malabsorption, malnutrition.
|
---|
| 42 | ;; 3. Hematemesis or melena (describe any episodes).
|
---|
| 43 | ;; 4. Pain or tenderness-location, type, precipitating factors.
|
---|
| 44 | ;; 5. Liver size, superficial abdominal veins.
|
---|
| 45 | ;; 6. Muscle strength and wasting.
|
---|
| 46 | ;; 7. Any other signs of liver disease, e.g., palmar erythema,
|
---|
| 47 | ;; spider angiomata, etc.
|
---|
| 48 | ;;TOF
|
---|
| 49 | ;;D. Diagnostic and Clinical Tests:
|
---|
| 50 | ;;
|
---|
| 51 | ;; 1. For esophageal varices, X-ray, endoscopy, etc.
|
---|
| 52 | ;; 2. For adhesions, X-ray to show partial obstruction, delayed motility.
|
---|
| 53 | ;; 3. For gall bladder disease, X-ray or other objective confirmation.
|
---|
| 54 | ;; 4. For liver disease:
|
---|
| 55 | ;; * Liver function tests (albumin, prothrombin time, bilirubin, AST,
|
---|
| 56 | ;; ALT, WBC, platelets).
|
---|
| 57 | ;; * Serologic tests for hepatitis (HBsAg, anti-HCV (EIA or ELISA) anti-
|
---|
| 58 | ;; HBc, ferritin, alpha-fetoprotein); and liver imaging (ultrasound or
|
---|
| 59 | ;; abdominal CT scan), as appropriate.
|
---|
| 60 | ;; * If hepatitis C is the suspected diagnosis, a positive EIA (enzyme
|
---|
| 61 | ;; immunoassay) test for hepatitis C should be confirmed by a RIBA
|
---|
| 62 | ;; (recombinant immunoblot assay) test OR by an HCV RNA test,
|
---|
| 63 | ;; either qualitative or quantitative. The diagnosis of hepatitis
|
---|
| 64 | ;; C infection should not be made unless such test results are
|
---|
| 65 | ;; in the record and support the diagnosis. A positive EIA test alone
|
---|
| 66 | ;; is not sufficient to establish the diagnosis, nor is a liver biopsy
|
---|
| 67 | ;; with a report that indicates it is "consistent with"
|
---|
| 68 | ;; hepatitis C infection.
|
---|
| 69 | ;; * With a diagnosis of hepatitis, name the specific type (A, B, C, or
|
---|
| 70 | ;; other), and for hepatitis B and C, provide an opinion as to which risk
|
---|
| 71 | ;; factor is the most likely cause. Support the opinion by discussing all
|
---|
| 72 | ;; risk factors in the individual and the rationale for your opinion. If
|
---|
| 73 | ;; you can not determine which risk factor is the likely cause, state that
|
---|
| 74 | ;; there is no risk factor that is more likely than another
|
---|
| 75 | ;; to be the cause, and explain.
|
---|
| 76 | ;; * With a diagnosis of cirrhosis, chronic hepatitis, liver malignancy, or
|
---|
| 77 | ;; other chronic liver disease, state the most likely etiology and the
|
---|
| 78 | ;; basis for your opinion. Address the relationship of the disease to
|
---|
| 79 | ;; active service, including any hepatitis or hepatitis risk factor that
|
---|
| 80 | ;; occurred in service. If you cannot determine the most likely
|
---|
| 81 | ;; etiology, cannot determine whether it is more likely than not that one
|
---|
| 82 | ;; of multiple risk factors is the cause, or cannot determine whether it
|
---|
| 83 | ;; is at least as likely as not that the liver disease is related
|
---|
| 84 | ;; to service, so state and explain.
|
---|
| 85 | ;; 5. Include results of all diagnostic and clinical tests conducted in the
|
---|
| 86 | ;; examination report.
|
---|
| 87 | ;;
|
---|
| 88 | ;;
|
---|
| 89 | ;;E. Diagnosis:
|
---|
| 90 | ;;
|
---|
| 91 | ;;
|
---|
| 92 | ;;Signature: Date:
|
---|
| 93 | ;;END
|
---|